Visual
Redefining Healthy Longevity
Through Precision Immune Resilience

Advancing Immune Cell Platforms
for Recovery Beyond Treatment

IMMUNIQUE develops next-generation immune cell platforms that
restore immune resilience and promote recovery beyond treatment.

Through immune reprogramming and precision cell therapies, we are shaping a future where
healthcare extends beyond disease treatment toward healthier, longer lives.

We are redefining the future of immune therapeutics.

View More

Platform

PRIME-NK

An Innate Immunity-Based NK Platform
for Recovery Beyond Treatment

Powered by scalable feeder-free manufacturing,
PRIME-NK harnesses innate immunity to restore immune resilience,
promote tissue regeneration, and redefine recovery
after cancer treatment.
View More
PRIME-NK 플랫폼

Platform

IMMUNOKINE

An AI-Driven Cytokine-Mimetic Peptide Platform
for Precision Immunomodulation
IMMUNOKINE is an AI-driven platform
for discovering cytokine-mimetic peptides,
enabling precise immune modulation
for next-generation immunotherapies.
View More
IMMUNOKINE 플랫폼

Platform

AUTO-Treg

Autologous Treg-Based Platform
for Immune Tolerance Restoration

AUTO-Treg is a patient-derived Treg platform
with optimized function and reproducible manufacturing,
designed to restore immune homeostasis in autoimmune
and immune-mediated diseases.
View More
AUTO-Treg 플랫폼

Pipeline

3ㄴㄴㄴ대 플랫폼 기반의 파이프라인
이뮤니크는 Prime-NK(NK 기반 회복 치료), Immunokine(AI 기반 사이토카인 유사 펩타이드), Auto-Treg(자가유래 Treg )의 3대 축을 중심으로
파이프라인을 전개하며, 상업 파일럿과 PoC 결과를 기반으로 적응증을 단계적으로 확장합니다.
자세히 보기
Immune Resilience for Longevity

PR